Cargando…
“ISTH guidelines for antithrombotic treatment in COVID‐19”: Comment from Huisman et al.
Autores principales: | Huisman, Menno V., Klok, Frederikus A., Kamphuisen, Pieter W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801168/ https://www.ncbi.nlm.nih.gov/pubmed/36271456 http://dx.doi.org/10.1111/jth.15855 |
Ejemplares similares
-
“ISTH guidelines for antithrombotic treatment in COVID‐19”: Reply
por: Schulman, Sam, et al.
Publicado: (2022) -
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19: A comment
por: Barrett, Christopher D., et al.
Publicado: (2020) -
Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance
por: Schutgens, Roger E.G., et al.
Publicado: (2023) -
Assessment of Patients with von Willebrand Disease with ISTH/BAT and PBQ Scores
por: Belen Apak, Fatma Burcu, et al.
Publicado: (2020) -
RE: ISTH interim guidance to recognition and management of coagulopathy in COVID‐19
por: Akima, Satoshi, et al.
Publicado: (2020)